Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.3 (
phospholipase C
)
18,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Phosphoinositide (PI) 3-kinase enhancer (
PIKE
) is a brain-specific GTPase that binds to PI 3-kinase and stimulates its lipid kinase activity. It exists in two forms: the first to be identified,
PIKE
-S, is shorter and exclusively nuclear; by contrast, the longer form,
PIKE
-L, resides in multiple intracellular compartments. Nerve growth factor treatment leads to
PIKE
-S activation by triggering the nuclear translocation of
phospholipase C
(
PLC
)-gamma 1, which acts as a physiological guanine nucleotide exchange factor (GEF) for
PIKE
-S through its Src-homology 3 (SH3) domain. Cytoplasmic PI 3-kinase and its lipid product phosphatidylinositol (3,4,5)-trisphosphate [PtdIns(3,4,5)P3] regulate the membrane translocation and activation of many signaling molecules by binding to their pleckstrin homology (PH) domains. However, little is known about the physiological roles of their nuclear counterparts. The nuclear
PLC
-gamma 1/
PIKE
-S/PI 3-kinase signaling pathway seems to be an extension of the crosstalk between cytoplasmic
PLC
-gamma 1 and PI 3-kinase.
PIKE
-L contains a C-terminal extension consisting of an ADP ribosylation-GTPase-activating protein (ArfGAP) domain and two ankyrin repeats in addition to the N-terminal GTPase domain.
PIKE
-L could have additional, extranuclear functions, including regulation of postsynaptic signaling by metabotropic glutamate receptors.
...
PMID:PIKE GTPase: a novel mediator of phosphoinositide signaling. 1467 71
Although
phospholipase C
-gamma (PLC-gamma) participates in cellular mitogenesis, evidence indicates that the catalytic activity of PLC-gamma (to hydrolyze certain phosphoinositides) is nonessential to the process. So how is it that PLC-gamma is necessary but its lipase activity is not? Recently published results from Snyder and colleagues describe the ability of PLC-gamma to facilitate guanine nucleotide exchange for the recently identified nucleus-localized GTPase
PIKE
, which acts to enhance the enzymatic activity of phosphatidylinositol 3'-kinase (PI3K). The authors contend that the SH3 domain, rather than the catalytic domain, of PLC-gamma is required for aiding
PIKE
, and furthermore, that the mitogenic activity of PLC-gamma depends not on its phospholipase activity, but rather on its interaction with
PIKE
. Wang and Moran examine the results and piece together a picture of how PLC-gamma cooperates with
PIKE
.
...
PMID:Phospholipase C-gamma1: a phospholipase and guanine nucleotide exchange factor. 1499 10
PIKE
(PI 3-Kinase Enhancer) is a recently identified brain specific nuclear GTPase, which binds PI 3-kinase and stimulates its lipid kinase activity. Nerve growth factor treatment leads to
PIKE
activation by triggering the nuclear translocation of
phospholipase C
-gamma1 (PLC-gamma1), which acts as a physiologic guanine nucleotide exchange factor (GEF) for
PIKE
through its SH3 domain. To date, three forms of
PIKE
have been characterized:
PIKE
-S,
PIKE
-L and
PIKE
-A.
PIKE
-S is initially identified shorter isoform.
PIKE
-L, a longer isoform of
PIKE
gene, differs from
PIKE
-S by C-terminal extension containing Arf-GAP (ADP ribosylation factor-GTPase Activating Protein) and two ankyrin repeats domains. In contrast to the exclusive nuclear localization of
PIKE
-S,
PIKE
-L occurs in both the nucleus and the cytoplasm.
PIKE
-L physiologically associates with Homer 1, an mGluR I binding adaptor protein. The Homer/
PIKE
-L complex couples PI 3-kinase to mGluR I and regulates a major action of group I mGluRs, prevention of neuronal apoptosis. More recently, a third
PIKE
isoform,
PIKE
-A was identified in human glioblastoma multiforme brain cancers. Unlike the brain specific
PIKE
-L and -S isoforms,
PIKE
-A distributes in various tissues.
PIKE
-A contains the same domains present in
PIKE
-L but lacks N-terminal proline-rich domain (PRD), which binds PI 3-kinase and PLC-gamma1. Instead,
PIKE
-A specifically binds to active Akt and upregulates its activity in a GTP-dependent manner, mediating human cancer cell invasion and preventing apoptosis. Thus,
PIKE
extends its roles from the nucleus to the cytoplasm, mediating cellular processes from cell invasion to programmed cell death.
...
PMID:PIKE GTPase signaling and function. 1595 49